BREAKING: More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately

More than Half of the U.S. House Asks Azar to Address Drug Makers’ 340B Actions Immediately

More than half of the U.S. House today told U.S. Health and Human Services (HHS) Secretary Alex Azar “it is imperative that immediate action

Read More »

BREAKING: House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

House Democratic Committee Chairs Say Drug Companies’ Actions Could Put 340B on “Treacherous Path”

Letting drug manufacturers “pick and choose” which 340B program requirements they will comply with “could set us on a treacherous path where program participants might disregard

Read More »

A Closer Look at Democratic VP Choice Harris’s Positions on the 340B Program

A Message from Publisher and CEO Ted Slafsky: Please join us in welcoming AllianceRx Walgreens Prime as the newest 340B Report sponsor. We are very pleased to have them on board. For now, we have more requests for sponsorships than space

Read More »

340B Bill Introduced in House; Senate 340B Bill Gets Two More Sponsors

340B Bill Introduced in House; Senate 340B Bill Gets Two More Sponsors

U.S. Reps. Doris Matsui (D-Calif.) and Chris Stewart (R-Utah) yesterday introduced their bill (H.R. 7838) to protect hospitals from losing eligibility for 340B drug discounts and to

Read More »

A Bipartisan Bill Will Be Introduced in the U.S. House Soon to Protect 340B Hospitals During the Pandemic


Editor’s note: Please be sure to read this issue’s sponsored content article from Comprehensive Pharmacy Services. The ability to publish sponsored content is one of the many benefits of becoming a 340B Report sponsor. Click on

Read More »

Key House Committee Rejects HRSA Request for More Regulatory Authority


A Message from Publisher and CEO Ted Slafsky: Happy Tuesday from sunny Washington, D.C.! I encourage you to read Comprehensive Pharmacy Services’ (CPS) article about its new white paper on navigating the 340B program during the COVID-19

Read More »

BREAKING: New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic

New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic

New bipartisan legislation in the U.S. Senate would “would provide certainty to hospitals participating in the 340B drug discount program during the COVID-19 public health emergency,” its

Read More »

House Bipartisan Bills Address Worries About COVID-19 Drug Price Gouging


A Message from Publisher and CEO Ted Slafsky:  Not only has the COVID-19 pandemic taken an enormous toll on health care workers, it has also been a major hit to 340B covered entities’ finances. I encourage

Read More »

Largest Hospital Group Asks Congress to Reject Administration's "Harmful" 340B Policy Requests

Greetings from 340B Report Publisher and CEO Ted Slafsky as my wife Diane and I celebrate 25 years of marriage today! Please join us in welcoming Hudson Headwaters 340B to our growing group of 340B Report sponsors. Our

Read More »

Sasse Reintroduces Bill in U.S. Senate to Keep Hospitals from Losing 340B Eligibility During Pandemic


A note from 340B Report Publisher and CEO Ted Slafsky: Today’s issue continues our ongoing series of articles by 340B Report sponsors that draw on their deep expertise. Click on the button below or reach me

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live